Research and Data Analysis
Program Funding
Annual program obligations reported to SAM.gov.
Who has received this funding
Organizations awarded under CFDA 95.007 (USAspending.gov).
- National Association Of County And City Health Officials $1,200,000
- National Foundation For The Centers For Disease Control & Prevention, Inc. $700,000
- American College Of Medical Toxicology, Inc. $400,000
- University Of Florida $299,801
- University Of Maryland, College Park $150,000
- University Of Baltimore
Program Objective
The purpose of research and data analysis is to inform policy formulation and assessment. The work involves research and analysis of data as it pertains to drug policy.
Eligibility
Eligible Applicants
- Nonprofit Organization
Applicants must have expert knowledge and extensive experience in conducting research and analysis to include higher educational institutions and hospitals. Applicants must also ensure compliance with all federal laws, regulations, Executive Orders, and public policies governing financial assistance awards.
How to Apply
Award Procedure
Upon approval by ONDCP, an award and conditions are sent to the awardee electronically.
Decision Timeline
- Approval: From 30 to 60 days
Program details & compliance
Description
The purpose of research and data analysis is to inform policy formulation and assessment. The work involves research and analysis of data as it pertains to drug policy.
Mission Categories
Primary: Research and Development
Use of Funds
Allowed Uses
ONDCP is seeking a provider to conduct research and data analysis on relevant drug topics.
Required Documentation
Applicants must have expert knowledge and extensive experience in conducting research and analysis.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements
Formula
Authority: 21 U.S.C. 1706; 21 U.S.C. 1703(d), 1703(f), 21 U.S.C. 1701, 21 U.S.C. 1521-1548, 21 U.S.C. 2001-2003, Office of National Drug Control Policy Reauthorization Act of 2006, P.L 109-469 (2006), 2 CFR part 200.
Source: 79 FR 76105, Dec. 19, 2014, unless otherwise noted.
§ 3603.1 Adoption of 2 CFR Part 200.
Under the authority listed above, the Executive Office of the President, Office of National Drug Control Policy (ONDCP) adopts the Office of Management and Budget (OMB) Guidance in 2 CFR part 200. Thus, this part gives regulatory effect to the OMB guidance and supplements the guidance as needed for ONDCP.